ES8702881A1 - Un procedimiento para la preparacion de etanodiimidamidas - Google Patents

Un procedimiento para la preparacion de etanodiimidamidas

Info

Publication number
ES8702881A1
ES8702881A1 ES551506A ES551506A ES8702881A1 ES 8702881 A1 ES8702881 A1 ES 8702881A1 ES 551506 A ES551506 A ES 551506A ES 551506 A ES551506 A ES 551506A ES 8702881 A1 ES8702881 A1 ES 8702881A1
Authority
ES
Spain
Prior art keywords
histamine
substituted
thiadiazoles
diamino
receptor antagonist
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES551506A
Other languages
English (en)
Other versions
ES551506A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of ES8702881A1 publication Critical patent/ES8702881A1/es
Publication of ES551506A0 publication Critical patent/ES551506A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/48—Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE ETANODIIMIDAMIDAS. CONSISTE EN TRATAR UN COMPUESTO DE FORMULA (II) CON UN ACIDO MINERAL FUERTE, TAL COMO HCL, EN UN DISOLVENTE INERTE Y A TEMPERATURA AMBIENTE, PARA OBTENER ETANODIIMIDAMIDAS DE FORMULA (I) O SUS SALES DE ADICION DE ACIDO CORRESPONDIENTES, DONDE R1 ES HIDROGENO, ALQUILO INFERIOR, 2-FLUORETILO, 2,2,2-TRIFLUORETILO, ALQUILO Y OTROS; M ES UN NUMERO ENTERO DE 0 A 2 INCLUSIVE; N ES UN NUMERO ENTERO DE 2 A 5 INCLUSIVE; Z ES OXIGENO, AZUFRE O METILO; Y A ES UN ANILLO HETEROCICLICO DE 5 O 6 MIEMBROS QUE CONTIENE COMO MINIMO UN ATOMO DE NITROGENO Y UNO O DOS HETEROATOMOS ADICIONALES SELECCIONADOS ENTRE AZUFRE, OXIGENOS Y NITROGENO. TIENEN APLICACIONES FARMACOLOGICAS POR SER POTENTES ANTAGONISTAS DE LOS RECEPTORES H2 DE LA HISTAMINA.
ES551506A 1984-06-22 1986-01-31 Un procedimiento para la preparacion de etanodiimidamidas Expired ES8702881A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/623,588 US4644006A (en) 1984-06-22 1984-06-22 Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity

Publications (2)

Publication Number Publication Date
ES8702881A1 true ES8702881A1 (es) 1987-01-16
ES551506A0 ES551506A0 (es) 1987-01-16

Family

ID=24498651

Family Applications (2)

Application Number Title Priority Date Filing Date
ES544409A Expired ES8702902A1 (es) 1984-06-22 1985-06-21 Un procedimiento para la preparacion de 3,4-diamino-1,2,5-tiadiazoles sustituidos.
ES551506A Expired ES8702881A1 (es) 1984-06-22 1986-01-31 Un procedimiento para la preparacion de etanodiimidamidas

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES544409A Expired ES8702902A1 (es) 1984-06-22 1985-06-21 Un procedimiento para la preparacion de 3,4-diamino-1,2,5-tiadiazoles sustituidos.

Country Status (33)

Country Link
US (1) US4644006A (es)
JP (2) JPS6118775A (es)
KR (1) KR900004321B1 (es)
AR (1) AR240935A1 (es)
AT (1) AT390790B (es)
AU (2) AU580605B2 (es)
BE (1) BE902724A (es)
CA (2) CA1267412A (es)
CH (1) CH665210A5 (es)
CS (1) CS257276B2 (es)
DD (1) DD240889A5 (es)
DE (1) DE3522101A1 (es)
DK (1) DK282885A (es)
ES (2) ES8702902A1 (es)
FI (1) FI852405L (es)
FR (1) FR2566406B1 (es)
GB (2) GB2161157B (es)
GR (1) GR851514B (es)
HU (1) HU193992B (es)
IE (2) IE58261B1 (es)
IL (1) IL75567A0 (es)
IT (1) IT1190372B (es)
LU (1) LU85969A1 (es)
NL (1) NL8501766A (es)
NO (1) NO161856C (es)
NZ (1) NZ212403A (es)
OA (1) OA08039A (es)
PT (1) PT80684B (es)
SE (1) SE464305B (es)
SU (1) SU1537136A3 (es)
YU (2) YU45725B (es)
ZA (1) ZA854710B (es)
ZW (1) ZW10385A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0535227A4 (en) * 1990-05-29 1993-08-18 Nippon Soda Co., Ltd. N-substituted heterocyclic amidine derivative
WO2022034121A1 (en) 2020-08-11 2022-02-17 Université De Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3657237A (en) * 1968-05-22 1972-04-18 Frosst & Co Charles E Process for making 1 2 5-thiadiazoles in the sinister configuration
DK160611C (da) * 1979-09-04 1991-09-16 Bristol Myers Squibb Co Analogifremgangsmaade til fremstilling af 3,4-disubstituerede 1,2,5-thiadiazol-1-oxider og -1,1-dioxider
DE3175201D1 (en) * 1980-04-30 1986-10-02 Merck & Co Inc Aminothiadiazoles as gastric secretion inhibitors
US4394508A (en) * 1980-06-07 1983-07-19 Bristol-Myers Company Chemical compounds
EP0045155B1 (en) * 1980-07-30 1985-01-02 Imperial Chemical Industries Plc Guanidine derivatives
EP0060730A3 (en) * 1981-03-18 1982-12-08 Imperial Chemical Industries Plc Bicyclic derivatives
EP0065823A1 (en) * 1981-05-13 1982-12-01 Imperial Chemical Industries Plc Heterocyclic guanidines as histamine H-2 antagonists
US4528377A (en) * 1982-03-29 1985-07-09 Bristol-Myers Company Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
FR2542741B1 (fr) * 1982-03-29 1989-12-08 Bristol Myers Co 3,4-diamino-1,2,5-thiadiazoles substitues possedant une activite antagoniste du recepteur-h2 de l'histamine
US4528378A (en) * 1982-03-29 1985-07-09 Bristol-Myers Company Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
US4528375A (en) * 1982-03-29 1985-07-09 Bristol-Myers Company Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
US4588826A (en) * 1982-03-29 1986-05-13 Bristol-Myers Company Ethanediimidamide intermediates
US4517366A (en) * 1982-03-29 1985-05-14 Bristol-Myers Company Intermediates for preparing 3,4-diamino-1,2,5-thiadiazoles
FI832519L (fi) * 1982-07-12 1984-01-13 Bristol Myers Co Farmaceutiska foerfaranden och sammansaettningar
US4520025A (en) * 1982-07-21 1985-05-28 William H. Rorer, Inc. Bicyclic nitrogen heterocyclic ethers and thioethers, and their pharmaceutical uses
JPS5978171A (ja) * 1982-10-26 1984-05-04 Ikeda Mohandou:Kk 複素環式化合物
US4440933A (en) * 1983-03-16 1984-04-03 Bristol-Myers Company Process for preparing 1,2,5-thiadiazoles

Also Published As

Publication number Publication date
SE464305B (sv) 1991-04-08
AU2977589A (en) 1989-06-01
NO852519L (no) 1985-12-23
IE58261B1 (en) 1993-08-25
ES8702902A1 (es) 1987-01-16
AR240935A1 (es) 1991-03-27
HU193992B (en) 1987-12-28
YU102587A (en) 1988-02-29
LU85969A1 (fr) 1986-01-24
GB8515749D0 (en) 1985-07-24
DD240889A5 (de) 1986-11-19
GB2192884A (en) 1988-01-27
US4644006A (en) 1987-02-17
KR900004321B1 (ko) 1990-06-22
FI852405A0 (fi) 1985-06-17
ES551506A0 (es) 1987-01-16
CH665210A5 (de) 1988-04-29
IE851557L (en) 1985-12-22
SU1537136A3 (ru) 1990-01-15
HUT42087A (en) 1987-06-29
PT80684A (en) 1985-07-01
IE57937B1 (en) 1993-05-19
AU580605B2 (en) 1989-01-19
YU105185A (en) 1987-12-31
YU45822B (sh) 1992-07-20
NO161856B (no) 1989-06-26
DK282885A (da) 1985-12-23
PT80684B (en) 1987-05-08
IT1190372B (it) 1988-02-16
CA1267412A (en) 1990-04-03
AT390790B (de) 1990-06-25
SE8503110L (sv) 1985-12-23
IT8521217A0 (it) 1985-06-20
ZA854710B (en) 1986-02-26
SE8503110D0 (sv) 1985-06-20
FR2566406B1 (fr) 1988-01-29
BE902724A (fr) 1985-12-23
ZW10385A1 (en) 1986-02-05
ATA185885A (de) 1989-12-15
DK282885D0 (da) 1985-06-21
NZ212403A (en) 1989-04-26
DE3522101A1 (de) 1986-01-02
JPS61186369A (ja) 1986-08-20
CS424785A2 (en) 1987-09-17
NL8501766A (nl) 1986-01-16
NO161856C (no) 1989-10-04
KR860000275A (ko) 1986-01-27
GB2192884B (en) 1988-08-10
AR240935A2 (es) 1991-03-27
FI852405L (fi) 1985-12-23
GR851514B (es) 1985-11-25
IL75567A0 (en) 1985-10-31
AU614331B2 (en) 1991-08-29
CA1297875C (en) 1992-03-24
GB2161157A (en) 1986-01-08
GB2161157B (en) 1988-08-10
ES544409A0 (es) 1987-01-16
GB8716149D0 (en) 1987-08-12
FR2566406A1 (fr) 1985-12-27
AU4392085A (en) 1986-01-02
JPS6118775A (ja) 1986-01-27
OA08039A (fr) 1987-01-31
CS257276B2 (en) 1988-04-15
YU45725B (sh) 1992-07-20

Similar Documents

Publication Publication Date Title
EP0251299A3 (en) Cephalosporin compounds, processes for their preparation and antibacterial agents
CA2124680A1 (en) Piperazine derivatives as 5-ht1a antagonists
ES8602721A1 (es) Un procedimiento para la preparacion de antagonistas de los receptores h-2 de la histamina.
AU593207B2 (en) Novel phenyl-substituted sulfonamides
IE40570L (en) Benzylamine derivatives
ES8801289A1 (es) Un metodo para preparar derivados de cefem
PH23065A (en) Tricyclic oxindole antiinflammatory agents
CA1228067A (en) 3,4-DIAMINO-1,2,5-THIADIAZOLE SUBSTITUTION DERIVATIVES, ANTAGONISTS FOR H.SUB.2 HISTAMINE RECEPTORS
ES8702902A1 (es) Un procedimiento para la preparacion de 3,4-diamino-1,2,5-tiadiazoles sustituidos.
ES8505978A1 (es) Un procedimiento para la preparacion de antagonistas de los receptores hidrogeno de la histamina.
ES8604603A1 (es) Un procedimiento para preparar derivados de 4,5,6,7-tetrahidrotiazolo (4,5-c) piridina
IL85725A0 (en) Imidazole derivatives,their manufacture and pharmaceutical compositions containing them
ES8706128A1 (es) Un procedimiento para la preparacion de derivados de imidazol triciclicos
ES8506641A1 (es) Procedimiento para preparar 1-acetonil-2-(fenilimino)-imidazolidinas
AU552397B2 (en) Imadazoline substituted benzdioxan derivatives
JPS56131571A (en) Novel hetero ring substituted carboxyamide and methyl amine compound
ATE65986T1 (de) Propanolabkoemmlinge.
EP0177897A3 (en) Antibacterial 7beta-heterocyclic-cephem
DE3469738D1 (en) Spirobenzofuranones, their production and use
GB1187779A (en) Dihydrobenzofuran Derivatives

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970401